Stugeron for circulatory disorders in the brain and extremities

Stugeron prescribed to prevent nausea and vomiting caused by travel sickness, chemotherapy or Meniere’s disease. It is also used to control vertigo, balance disorders and tinnitus. Sometimes doctors can prescribe Stugeron when treating migraine attacks.

Stugeron is also used, together with other medicines, in the treatment of cerebral ischemic disorders that cause confusion or labyrinth, as well as in cases of ischaemia of the extremities.

Stugeron has shown a beneficial effect in the treatment of vertigo and tinnitus associated with Meniere’s disease. Meniere’s disease is a condition of the inner ear that causes episodes of vertigo (feeling dizzy), hearing loss, and tinnitus (ringing in the ears). These attacks can vary in severity and frequency. Despite STUGERON’s beneficial effects in treating symptoms of dizziness, nausea, and tinnitus, its use is limited, due to the increased levels of drowsiness caused by the drug.

Stugeron will help reduce the feeling of nausea, dizziness, and tinnitus caused by problems such as: Meniere’s disease, travel sickness, migraine, and Stugeron can also contribute to the treatment of disorders caused by peripheral or cerebral circulation disorders. Stugeron can be taken by adults and children over 5 years of age.


  1. Treatment or prevention of balance problems (such as Meniere’s disease)
  2. Prevention of motion sickness, or travel sickness
  3. Prevention of vertigo and nausea during migraine attacks.
  4. Supportive treatment to combat symptoms resulting from peripheral circulatory disorders, such as: Raynaud’s phenomenon, acrocyanosis, intermittent claudication, and other diseases that occur as a result of poor peripheral circulation.
  5. Treatment of symptoms due to cerebral circulatory insufficiency, including dizziness, tinnitus, vascular headache, irritability, memory loss, and lack of concentration.


  • Dosage for cerebrovascular disorders: 25 mg of Cinnarizine (one tablet) three times daily.
  • Dosage for disorders due to peripheral circulatory disorders: 50 to 75 mg of Cinnarizine (2 to 3 tablets) three times daily.
  • Dosage for balance disorders: 25 mg (one tablet) three times daily.
  • The dose for motion sickness or travel sickness for adults: 25 mg of Cinnarizine (one tablet) taken half an hour before the start of travel, and the dose is repeated every 6 hours.
  • Dosage for motion sickness or travel sickness in children (over 5 years): Half the adult dose.

How does Stugeron work?

Cinnarizine (the active ingredient in Stugeron) is thought to work by improving blood flow in the inner ear, which contributes to reducing pressure buildup and relieving symptoms. Stugeron has antihistamine properties, which makes the medicine drowsy.

Instructions for use

Take Stugeron exactly as directed by your doctor. The dose is usually three times daily at first, then after symptoms are controlled, the doctor may lower the dose.

It is preferable to take a dose of Stugeron half an hour before a meal, but if the medicine causes discomfort in the digestive system, the dose can be taken after meals to reduce the side effect on the digestive system. It is recommended to take the doses at the same times each day.

If you forget a dose, do not worry, just remember to take the next dose on time, and do not double the dose to make up for the forgotten dose.

If you are a driver, you must stop driving when you are diagnosed with Meniere’s disease. Stugeron can make you drowsy, and the disease also affects the ability to drive as a result of dizziness and lightheadedness, and you should not return to driving vehicles until the condition is completely stable.

It is unlikely that STUGERON will stop all attacks of Meniere’s disease, but it will reduce their number and severity. Some people with Meniere’s disease think their symptoms will improve with a low-salt diet, regular exercise, stopping smoking, or cutting out caffeine and alcohol, but there is little evidence for this, though it’s worth trying.

The maximum recommended dose should not be exceeded (225 mg cinnarizine/day). Since the effect of Stugeron on dizziness is dose dependent, the dose should be increased gradually.

Warnings and precautions

Stugeron should be prescribed with caution in the following patients:

  • the elderly .
  • Pregnant or breastfeeding women.
  • Patients with liver problems or kidney problems.
  • Parkinson’s disease
  • Patients with a blood disorder called acute porphyria.


It is forbidden to prescribe Stugeron in the following patients:

  • People allergic to cinnarizine.
  • Children under 5 years old.

Side effects

Drowsiness and disturbances in the digestive system may occur, and these symptoms are often transient and can be overcome with time and the appropriate dose is gradually reached.

In rare cases, headache, dryness in the throat, weight gain, and sweating may occur.

In elderly patients, involuntary and uncontrollable tremors may appear in parts of the body and face, and sometimes these symptoms are accompanied by a feeling of depression, and this usually occurs with long periods of treatment, and in this case it must be stopped treatment.

Product Ref: N07CA02